Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study.
Arthritis Res Ther
; 25(1): 91, 2023 06 01.
Article
in En
| MEDLINE
| ID: mdl-37264414
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Connective Tissue Diseases
/
Agammaglobulinemia
/
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Arthritis Res Ther
Journal subject:
REUMATOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Switzerland